Several other equities analysts have also recently issued reports on ESRX. Deutsche Bank initiated coverage on shares of Express Scripts in a research report on Monday, December 4th. They set a buy rating and a $75.00 price target on the stock. ValuEngine upgraded shares of Express Scripts from a hold rating to a buy rating in a research report on Monday, December 4th. TheStreet upgraded shares of Express Scripts from a c+ rating to a b- rating in a research report on Monday, December 4th. Sanford C. Bernstein upgraded shares of Express Scripts from an underperform rating to a market perform rating in a research report on Wednesday, December 6th. Finally, BidaskClub upgraded shares of Express Scripts from a hold rating to a buy rating in a research report on Thursday, December 14th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and eight have issued a buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus price target of $81.97.
Express Scripts (ESRX) opened at $80.75 on Thursday. Express Scripts has a 52-week low of $55.80 and a 52-week high of $85.07. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.55 and a current ratio of 0.67. The stock has a market cap of $45,320.00, a PE ratio of 10.43, a P/E/G ratio of 0.99 and a beta of 0.94.
Express Scripts declared that its Board of Directors has initiated a stock repurchase program on Monday, December 18th that permits the company to repurchase 45,000,000 outstanding shares. This repurchase authorization permits the company to reacquire shares of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its stock is undervalued.
In other news, VP Everett Neville sold 4,895 shares of the company’s stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $75.26, for a total value of $368,397.70. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Christine Houston sold 10,104 shares of the company’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $70.08, for a total transaction of $708,088.32. Following the completion of the transaction, the vice president now owns 87,400 shares in the company, valued at approximately $6,124,992. The disclosure for this sale can be found here. In the last quarter, insiders sold 21,896 shares of company stock worth $1,617,903. Insiders own 0.68% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of ESRX. SeaCrest Wealth Management LLC bought a new position in shares of Express Scripts in the fourth quarter worth approximately $105,000. Bank of Nova Scotia Trust Co. bought a new position in Express Scripts during the third quarter valued at approximately $120,000. Aevitas Wealth Management Inc. bought a new position in Express Scripts during the fourth quarter valued at approximately $128,000. Financial Gravity Companies Inc. bought a new position in Express Scripts during the fourth quarter valued at approximately $142,000. Finally, Monroe Bank & Trust MI lifted its position in Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock valued at $156,000 after purchasing an additional 970 shares during the period. Hedge funds and other institutional investors own 87.70% of the company’s stock.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.